In the special “GENETIC INSTABILITY” of Swiss Oncology in Motion, Prof. Dr. med. Viola Heinzelmann-Schwarz (University Hospital Basel), Prof. Dr. med. Jens Huober (Canton Hospital St. Gallen), PD Dr. med. Aurelius Omlin (OnkoZentrum Zürich), Prof. Dr. med. Dr. phil. Andreas Wicki (University Hospital Zurich) and Prof. Dr. med. Wolfram Jochum (Cantonal Hospital St. Gallen) discussed the role of genetic instability in various tumor types, in particular ovarian and endometrial carcinomas, breast carcionoma, GI tumors, and prostate, urothelial, and renal cell carcinomas, and how it influences treatment options. The discussion will be led by Prof. em. Richard Herrmann, MD, Basel, moderated.
You May Also Like
- Communication between hospitals and outpatient care
How does a digital clinical information system prove itself in everyday practice?
- Acute myeloid leukemia
Treatment decisions between MRD monitoring, transplantation and CAR-T cells
- Psoriasis and metabolic comorbidities: new study data
GLP-1RAs showed a valuable dual benefit
- Heart failure: combination of four as "Guideline-Directed Medical Therapy"
Standard established at HFrEF with individual nuances
- Chronic inflammation as a driver of ageing
Immunosenescence and inflammaging
- Evidence, limitations and practical implications
Phytotherapy for anxiety disorders
- Gonarthrosis and coxarthrosis: update on conservative treatment
Pain relief, targeted movement and relief
- Case report: Hiccups after ketoacidosis